Hancom Lifecare Inc. (KRX:372910)
South Korea · Delayed Price · Currency is KRW 3,010.00
-15.00 (-0.50%)
At close: Jan 30, 2026
Hancom Lifecare Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 88,613 | 104,776 | 112,780 | 100,120 | 121,140 | 151,842 |
Other Revenue | - | - | - | -0 | - | - |
| 88,613 | 104,776 | 112,780 | 100,120 | 121,140 | 151,842 | |
Revenue Growth (YoY) | -27.10% | -7.10% | 12.64% | -17.35% | -20.22% | 128.04% |
Cost of Revenue | 64,633 | 75,875 | 89,332 | 80,478 | 93,418 | 94,040 |
Gross Profit | 23,980 | 28,902 | 23,448 | 19,642 | 27,722 | 57,802 |
Selling, General & Admin | 18,702 | 19,481 | 19,403 | 18,634 | 20,480 | 17,697 |
Research & Development | 238.65 | 234.02 | 440.61 | 798.4 | 530.5 | 62.6 |
Amortization of Goodwill & Intangibles | 392.67 | 437.01 | 459.96 | 561.22 | 606.56 | 498.33 |
Other Operating Expenses | 305.18 | 354.32 | 364.49 | 412.76 | 239.3 | 331.08 |
Operating Expenses | 20,360 | 21,485 | 21,616 | 21,065 | 22,942 | 19,088 |
Operating Income | 3,620 | 7,416 | 1,832 | -1,423 | 4,781 | 38,714 |
Interest Expense | -19.56 | -31.45 | -182.08 | -131.58 | -468.74 | -6,893 |
Interest & Investment Income | 583.28 | 478.1 | 650.33 | 736.56 | 104.71 | 96.25 |
Currency Exchange Gain (Loss) | 392.42 | 1,207 | 256.32 | -142.03 | 788.62 | -259.37 |
Other Non Operating Income (Expenses) | -2,743 | -70.69 | -382.05 | -914.27 | -904.66 | 162.02 |
EBT Excluding Unusual Items | 1,833 | 9,000 | 2,175 | -1,874 | 4,301 | 31,821 |
Gain (Loss) on Sale of Investments | 63.77 | 8.87 | 5.33 | 23,920 | -39.44 | 563.03 |
Gain (Loss) on Sale of Assets | 14.55 | 73.98 | 157.83 | -18.34 | 1,333 | -49.09 |
Asset Writedown | - | - | -713.2 | -8,791 | - | - |
Pretax Income | 1,911 | 9,082 | 1,625 | 13,236 | 5,594 | 32,335 |
Income Tax Expense | -347.48 | 1,747 | 753.4 | 3,966 | 759.05 | 4,645 |
Earnings From Continuing Operations | 2,259 | 7,336 | 871.12 | 9,269 | 4,835 | 27,690 |
Minority Interest in Earnings | 11.52 | 38.76 | -46.41 | -65.47 | - | - |
Net Income | 2,270 | 7,375 | 824.71 | 9,204 | 4,835 | 27,690 |
Net Income to Common | 2,270 | 7,375 | 824.71 | 9,204 | 4,835 | 27,690 |
Net Income Growth | -64.77% | 794.20% | -91.04% | 90.36% | -82.54% | - |
Shares Outstanding (Basic) | 28 | 28 | 28 | 28 | 25 | 14 |
Shares Outstanding (Diluted) | 28 | 28 | 28 | 28 | 25 | 25 |
Shares Change (YoY) | - | - | - | 12.31% | -1.17% | 12366.52% |
EPS (Basic) | 82.04 | 266.48 | 29.80 | 332.58 | 196.22 | 1967.04 |
EPS (Diluted) | 82.00 | 266.00 | 29.80 | 332.58 | 196.00 | 1301.58 |
EPS Growth | -64.79% | 792.60% | -91.04% | 69.68% | -84.94% | - |
Free Cash Flow | 16,037 | 18,164 | -13,550 | -681.63 | 18,826 | -9,958 |
Free Cash Flow Per Share | 579.49 | 656.33 | -489.62 | -24.63 | 764.02 | -399.40 |
Gross Margin | 27.06% | 27.58% | 20.79% | 19.62% | 22.88% | 38.07% |
Operating Margin | 4.08% | 7.08% | 1.62% | -1.42% | 3.95% | 25.50% |
Profit Margin | 2.56% | 7.04% | 0.73% | 9.19% | 3.99% | 18.24% |
Free Cash Flow Margin | 18.10% | 17.34% | -12.01% | -0.68% | 15.54% | -6.56% |
EBITDA | 8,488 | 13,020 | 8,916 | 5,800 | 12,611 | 45,251 |
EBITDA Margin | 9.58% | 12.43% | 7.91% | 5.79% | 10.41% | 29.80% |
D&A For EBITDA | 4,868 | 5,604 | 7,084 | 7,223 | 7,831 | 6,536 |
EBIT | 3,620 | 7,416 | 1,832 | -1,423 | 4,781 | 38,714 |
EBIT Margin | 4.08% | 7.08% | 1.62% | -1.42% | 3.95% | 25.50% |
Effective Tax Rate | - | 19.23% | 46.38% | 29.97% | 13.57% | 14.37% |
Advertising Expenses | - | 706.96 | 764.06 | 1,094 | 865.79 | 777.2 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.